AbbVie
ABBV
ABBV
1,998 hedge funds and large institutions have $109B invested in AbbVie in 2017 Q4 according to their latest regulatory filings, with 275 funds opening new positions, 580 increasing their positions, 909 reducing their positions, and 51 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
0.3% more ownership
Funds ownership: 70.25% → 70.54% (+0.3%)
34% less call options, than puts
Call options by funds: $1.03B | Put options by funds: $1.55B
36% less repeat investments, than reductions
Existing positions increased: 580 | Existing positions reduced: 909
Holders
1,998
Holding in Top 10
164
Calls
$1.03B
Puts
$1.55B
Top Buyers
| 1 | +$626M | |
| 2 | +$506M | |
| 3 | +$386M | |
| 4 |
Goldman Sachs
New York
|
+$322M |
| 5 |
BlackRock
New York
|
+$263M |
Top Sellers
| 1 | -$429M | |
| 2 | -$385M | |
| 3 | -$344M | |
| 4 |
Bank of America
Charlotte,
North Carolina
|
-$281M |
| 5 |
Invesco
Atlanta,
Georgia
|
-$275M |